IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes.

Détails

ID Serval
serval:BIB_61CE22FDB0C0
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes.
Périodique
EMBO Journal
Auteur⸱e⸱s
Restivo G., Nguyen B.C., Dziunycz P., Ristorcelli E., Ryan R.J., Özuysal Ö.Y., Di Piazza M., Radtke F., Dixon M.J., Hofbauer G.F., Lefort K., Dotto G.P.
ISSN
1460-2075 (Electronic)
ISSN-L
0261-4189
Statut éditorial
Publié
Date de publication
2011
Volume
30
Numéro
22
Pages
4571-4585
Langue
anglais
Résumé
While the pro-differentiation and tumour suppressive functions of Notch signalling in keratinocytes are well established, the underlying mechanisms remain poorly understood. We report here that interferon regulatory factor 6 (IRF6), an IRF family member with an essential role in epidermal development, is induced in differentiation through a Notch-dependent mechanism and is a primary Notch target in keratinocytes and keratinocyte-derived SCC cells. Increased IRF6 expression contributes to the impact of Notch activation on growth/differentiation-related genes, while it is not required for induction of 'canonical' Notch targets like p21(WAF1/Cip1), Hes1 and Hey1. Down-modulation of IRF6 counteracts differentiation of primary human keratinocytes in vitro and in vivo, promoting ras-induced tumour formation. The clinical relevance of these findings is illustrated by the strikingly opposite pattern of expression of Notch1 and IRF6 versus epidermal growth factor receptor in a cohort of clinical SCCs, as a function of their grade of differentiation. Thus, IRF6 is a primary Notch target in keratinocytes, which contributes to the role of this pathway in differentiation and tumour suppression.
Mots-clé
Animals, Basic Helix-Loop-Helix Transcription Factors/metabolism, Cell Cycle Proteins/metabolism, Cell Differentiation, Cell Proliferation, Cyclin-Dependent Kinase Inhibitor p21/metabolism, Cyclin-Dependent Kinase Inhibitor p21/physiology, DNA-Binding Proteins/metabolism, Genes, Tumor Suppressor, Homeodomain Proteins/metabolism, Humans, Interferon Regulatory Factors/biosynthesis, Interferon Regulatory Factors/genetics, Keratinocytes/cytology, Keratinocytes/metabolism, Mice, Mice, Inbred NOD, Mice, SCID, Oncogene Protein p21(ras)/metabolism, Promoter Regions, Genetic, RNA Interference, RNA, Small Interfering, Receptor, Epidermal Growth Factor/biosynthesis, Receptor, Epidermal Growth Factor/genetics, Receptor, Notch1/genetics, Receptor, Notch1/metabolism, Signal Transduction, Skin Neoplasms/metabolism, Skin Neoplasms/pathology
Pubmed
Web of science
Open Access
Oui
Création de la notice
08/11/2011 16:27
Dernière modification de la notice
20/08/2019 15:18
Données d'usage